Innoviva Stock Alpha and Beta Analysis
| INVA Stock | USD 18.99 0.06 0.31% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Innoviva. It also helps investors analyze the systematic and unsystematic risks associated with investing in Innoviva over a specified time horizon. Remember, high Innoviva's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Innoviva's market risk premium analysis include:
Beta 0.6 | Alpha (0.09) | Risk 1.1 | Sharpe Ratio (0.03) | Expected Return (0.04) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Innoviva |
Innoviva Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Innoviva market risk premium is the additional return an investor will receive from holding Innoviva long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Innoviva. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Innoviva's performance over market.| α | -0.09 | β | 0.60 |
Innoviva expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Innoviva's Buy-and-hold return. Our buy-and-hold chart shows how Innoviva performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Innoviva Market Price Analysis
Market price analysis indicators help investors to evaluate how Innoviva stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innoviva shares will generate the highest return on investment. By understating and applying Innoviva stock market price indicators, traders can identify Innoviva position entry and exit signals to maximize returns.
Innoviva Return and Market Media
The median price of Innoviva for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 19.54 with a coefficient of variation of 1.98. The daily time series for the period is distributed with a sample standard deviation of 0.39, arithmetic mean of 19.53, and mean deviation of 0.33. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Raifeld Pavel of 150000 shares of Innoviva at 20.0 subject to Rule 16b-3 | 09/10/2024 |
2 | Innoviva, Inc.s Stock Is Going Strong Have Financials A Role To Play | 09/24/2024 |
3 | Acquisition by Bickerstaff George of 12647 shares of Innoviva subject to Rule 16b-3 | 09/26/2024 |
4 | Dimensional Fund Advisors LP Increases Stake in Innoviva, Inc. - MarketBeat | 09/27/2024 |
5 | Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024 | 10/15/2024 |
6 | Acquisition by Zhen Marianne of 1129 shares of Innoviva at 15.89 subject to Rule 16b-3 | 10/25/2024 |
7 | Innoviva Reports Third Quarter 2024 Financial Results Highlights Recent Company Progress | 11/06/2024 |
8 | Innoviva Third Quarter 2024 Earnings EPS US0.019 | 11/08/2024 |
9 | Innoviva Shows Rising Price Performance With Jump To 81 RS Rating | 11/13/2024 |
10 | Acquisition by Zhen Marianne of 300 shares of Innoviva subject to Rule 16b-3 | 11/15/2024 |
11 | Disposition of 976 shares by Zhen Marianne of Innoviva at 19.15 subject to Rule 16b-3 | 11/20/2024 |
12 | Acquisition by Haimovitz Jules of 16495 shares of Innoviva subject to Rule 16b-3 | 11/21/2024 |
13 | Two In Vitro Studies on Eravacycline Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity | 11/22/2024 |
14 | US Stock Innoviva | 11/27/2024 |
About Innoviva Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Innoviva or other stocks. Alpha measures the amount that position in Innoviva has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 22.61 | 23.7 | 25.25 | 28.92 | Receivables Turnover | 3.54 | 5.17 | 3.69 | 3.51 |
Innoviva Upcoming Company Events
As portrayed in its financial statements, the presentation of Innoviva's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Innoviva's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Innoviva's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Innoviva. Please utilize our Beneish M Score to check the likelihood of Innoviva's management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Innoviva
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Innoviva Backtesting, Innoviva Valuation, Innoviva Correlation, Innoviva Hype Analysis, Innoviva Volatility, Innoviva History and analyze Innoviva Performance. For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Innoviva technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.